Sickle cell disease and stroke in a pediatric population evidence-based diagnostic evaluation

Neuroimaging Clinics of North America

Volumn 13, Issue 2, 2003, Pages 185-196

  Winrow, Nevada ^a   Melhem, Elias R ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BRAIN ANGIOGRAPHY; BRAIN RADIOGRAPHY; CHILD; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; STROKE;

EID: 0037715166     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-5149(03)00030-3     Document Type: Review

References (40)

1. Powers D, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med 1978;65:461-71.
2. Ohene-Frempong K, Weiner S, Sleeper L, et al, and the Cooperative Study of Sickle Cell Disease. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998;91:288-94.
3. Armstrong FD, Thompson RJ, Wang W, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics 1996;97:864-70.
4. Brown RT, Buchanan I, Doepke K, et al. Cognitive and academic functioning in children with sickle cell disease. J Clin Child Psychol 1993;22:207-18.
5. Cohen MJ, Branch WB, Mckie VG, Adams RJ. Neuropsychological impairment in children with sickle cell anemia and cerebral vascular accidents. Clin Pediatr 1994;123:517-24.
6. Craft S, Schatz J, Glauser T, et al. Neuropsychological effects of stroke in children with sickle cell disease. J Pediatr 1993;123:712-7.
7. Glauser TA, Siegal MJ, Lee BCP, DeBaun MR. Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinapathy. J Child Neurol 1995;10:88-92.
8. Kinney T, Sleeper L, Wang W, et al. Silent cerebral infarction in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 1999;103:640-5.
9. Koshey M, Thomas C, Goodwin J. Vascular lesions in the central nervous system in sickle cell disease. J Assoc Acad Minor Phys 1990;1:62-6.
10. Kugler S, Anderson B, Cross D, et al. Abnormal cranial magnetic imaging scans in sickle cell disease. Arch Neurol 1993;50:629-35.
11. Moser F, Miller S, Bello J, et al. The spectrum of central nervous system abnormalities in sickle cell disease as defined by magnetic resonance imaging. AJNR Am J Neuroadiol 1996;17:965-72.
12. Swift AV, Cohen MJ, Hynd GW, et al. Neuropsychologic impairment in children with sickle cell anemia. Pediatrics 1989;84:1077-85.
13. Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002;99:3014-8.
14. Steen R, Reddick W, Mulhern R, et al. Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI. J Magn Reson Imaging 1998;8:535-43.
15. Powers DR, Conti P, Wong W, et al. Cerebral vasculopathy in sickle cell anemia, diagnostic contribution of positron emission tomography. Blood 1999;93:71-9.
16. Adams RJ, Nichols FT, Figueroa R, et al. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke 1992;23:1073-7.
17. Adams RJ, Nichols FT, McKie K, et al. Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology 1988;38:1012-7.
18. Stockman JA, Nigro MA, Mishkin MM, Osaki FA. Occlusion of large cerebral vessels in sickle cell anemia. N Engl J Med 1972;287:846-9.
19. Brass LM, Prohovnik I, Pavlakis SG, et al. Middle cerebral artery blood velocity and cerebral blood flow in sickle cell disease. Stroke 1991;22:27-30.
20. Verlhac S, Bemaudin F, Tortrat D, et al. Detection of cerebrovascular disease in patients with sickle cell disease using trancranial doppler sonography: correlation with MRI, MRA, and conventional angiography. Pediatr Radiol 1995;25(Suppl):S14-9.
21. Wiznitzer M, Ruggieri P, Masaryk T, et al. Diagnosis of cerebrovascular disease in sickle cell anemia by magnetic resonance angiography. J Pediatr 1990;117:551-5.
22. Pavlakis SG, Bello J, Prohovnik I, et al. Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol 1988;23:125-30.
23. Wang W, Langston J, Steen R, et al. Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr 1998;132:994-8.
24. Gillliams AR, McMahon L, Weinburg G, Carter AP. MRA of the intracranial circulation in asymptomatic patients with sickle cell disease. Pediatr Radiol 1998;28:283-7.
25. Huttenlocher PR, Mohr JW, Johns L, Brown FD. Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics 1984;73:615-21.
26. Adams RJ, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605-10.
27. Brass LM, Pavlakis SG, DeVivo D, et al. Transcranial Doppler measurements of the middle cerebral artery: effect of hematocrit. Stroke 1988;19:1466-9.
28. Winrow N. Neuropsychological and pathophysiological correlates of sickle cell disease in a pediatric population [dissertation]. Washington DC: Howard University; 1999.
29. Reed W, Jagust W, Al-Mateen M, Vichinsky E. Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease. Am J Hematol 1999;60:268-72.
30. Adams R, McKie V, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998;19:110-29.
31. Nichols F, Jones A, Adams R. Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing. J Neuroimaging 2001;11:354-62.
32. Kogutt MS, Goldwag SS, Gupta KL, et al. Correlation of transcranial Doppler ultrasonography with MRI and MRA in the evaluation of sickle cell disease patients with prior stroke. Pediatr Radiol 1994;24:204-6.
33. Kandeel Zimmerman RA, Ohene-Frempong K. Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability. Pediatr Radiol 1998;28:283-7.
34. DeBaun MR, Glauser TA, Siegel M, et al. Noninvasive central nervous system imaging in sickle cell anemia. A preliminary study comparing transcranial Doppler with magnetic resonance angiography. J Pediatr Hematol Oncol 1995;17:29-33.
35. Bulas DI, Jones A, Seibert JJ, et al. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol 2000;30:733-8.
36. Kirkham FJ, Calamante F, Bynevelt M, et al. Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Ann Neurol 2001;49:477-85.
37. DeBaun MR, Schatz J, Siegal MJ, et al. Cognitive screening examinations for silent cerebral infarctions in sickle cell disease. Neurology 1998;50:1678-82.
38. Jones AM, Seibert JJ, Nichols FT, Kinder DL, Cox K, Luden J, et al. Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia. Pediatr Radiol 2001;31:461-9.
39. Sorensen AG, Tievsky AL, Ostergaard L, Weisskoff RM, Rosen BR. Contrast agents in functional MR imaging. J Magn Reson Imaging 1997;7:47-55.
40. Oguz K, Golay X, Pizzini FB, Freer CA, Winrow N, Ichord R, et al. Continuous arterial spin labeling perfusion imaging in children with sickle cell disease. Radiology 2003;227:567-74.